Expression and biological role of the neutral cholesterol ester hydrolase 1 gene in liver cancer tissue and cell lines

Yuwen ZENG; Fangyong ZHANG; Guoqian TAN; Fan WU

doi:10.3969/j.issn.1001-5256.2021.08.023

Volume 37 Issue 8

Aug. 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2021 > 37(8): 1867-1872

PDF( 3035 KB)

Expression and biological role of the neutral cholesterol ester hydrolase 1 gene in liver cancer tissue and cell lines

DOI: 10.3969/j.issn.1001-5256.2021.08.023

Yuwen ZENG¹,
Fangyong ZHANG¹,
Guoqian TAN^{1, 2},
Fan WU^{1, 2
,
,}

1.
Department of Hepatobiliary Surgery, Guangzhou Red Cross Hospital Affiliated to Jinan University, Guangzhou 510220, China
2.
Department of Hepatobiliary Surgery, Guangzhou Red Cross Hospital, Guangzhou 510220, China

Research funding:

National Natural Science Foundation of China (81974442);

Province Natural Science Fund of Guangdong (2020A1515010799);

Guangdong Medical Science and Technology Research Fund (A2018028);

Guangzhou Health and Family Planning Science and Technology Project (2018A011022)

Received Date: 2021-03-09
Accepted Date: 2021-05-21
Published Date: 2021-08-20

Abstract

Abstract

Objective To investigate the expression of the neutral cholesterol ester hydrolase 1 (NCEH1) gene in liver cancer tissue and human hepatoma cell lines and the effect of NCEH1 gene knockdown on the proliferation, apoptosis, invasion, and metastasis abilities of human hepatoma SMMC-7721 cells. Methods Liver cancer tissue samples and adjacent tissue samples were collected from 32 patients with liver cancer who underwent surgical treatment in Guangzhou Red Cross Hospital Affiliated to Jinan University from January 2013 to June 2019, and quantitative real-time PCR was used to measure the relative expression level of the NCEH1 gene. Gene expression data of liver cancer samples up to September 2020 were downloaded from the ICGC database, and R software was used to analyze the data and obtain the expression level of the NCEH1 gene in each sample. The paired Wilcoxon signed-rank test and the Wilcoxon rank-sum test were used to investigate the differences between liver cancer tissue and adjacent tissue. Quantitative real-time PCR was used to measure the expression level of the NCEH1 gene in human hepatoma SMMC-7721, Bel-7402, HepG2, and Hep3B cells and normal human HL7702 liver cells. The lentivirus-mediated small interfering RNA (siRNA) technique was used to establish a human hepatoma SMMC-7721 cell line with NCEH1 gene knockdown, and the cells were divided into NCEH1 knockdown group (KD group) and negative control group (NC group); quantitative real-time PCR was used to measure the knockdown efficiency of the NCEH1 gene, and then MTT assay, flow cytometry with Annexin V-APC single staining, wound healing assay, Transwell assay, and Transwell chamber invasion assay were used to measure the proliferation, apoptosis, metastasis, and invasion abilities of SMMC-7721 cells in both groups. The t-test was used for statistical analysis of data between the two groups. Results The mean expression level of the NCEH1 gene in liver cancer tissue was significantly higher than that in adjacent tissue (specimens from our hospital: Z=2.263, P=0.024; ICGC database: U=18 768, P < 0.001). SMMC-7721 cell line with moderate potential of invasion and metastasis had the highest expression level of the NCEH1 gene, followed by BEL-7402 and HepG2 cell lines with low potential of invasion and metastasis, and Hep3B cell line without the potential of invasion and metastasis had the lowest expression level. The KD group had a significantly lower expression level of the NCEH1 gene than the NC group (t=11.578, P=0.000 3), and the knockdown efficiency of the NCEH1 gene was as high as 74.0%. Compared with the NC group, the KD group had a significant reduction in cell growth rate, a significant increase in apoptosis rate, and significant reductions in migration rate and the number of metastatic and invasive cells (t=32.100, 27.303, 9.51, 38.123, and 22.331, all P < 0.001). Conclusion There is a significant increase in the expression of the NCEH1 gene in liver cancer tissue and cell lines, and the NCEH1 gene can promote the growth, proliferation, invasion, and metastasis of hepatoma cells and inhibit their apoptosis, suggesting that it may be a potential therapeutic target for liver cancer.
- Carcinoma, Hepatocellular,
- Neutral Cholesterol Ester Hydrolase 1,
- RNA, Small Interfering

FullText(HTML)

References(23)

References

[1]	CHEN H, JIA W. Progress in hepatectomy for hepatocellular carcinoma and peri-operation management[J]. Genes Dis, 2020, 7(3): 320-327. DOI: 10.1016/j.gendis.2020.02.001.
[2]	ALI ES, RYCHKOV GY, BARRITT GJ. Deranged hepatocyte intracellular Ca²⁺ homeostasis and the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma[J]. Cell Calcium, 2019, 82: 102057. DOI: 10.1016/j.ceca.2019.102057.
[3]	ALY SM, FETAIH HA, HASSANIN A, et al. Protective effects of garlic and cinnamon oils on hepatocellular carcinoma in albino rats[J]. Anal Cell Pathol (Amst), 2019, 2019: 9895485. DOI: 10.1155/2019/9895485.
[4]	IGARASHI M, OSUGA J, UOZAKI H, et al. The critical role of neutral cholesterol ester hydrolase 1 in cholesterol removal from human macrophages[J]. Circ Res, 2010, 107(11): 1387-1395. DOI: 10.1161/CIRCRESAHA.110.226613.
[5]	CHANG JW, NOMURA DK, CRAVATT BF. A potent and selective inhibitor of KIAA1363/AADACL1 that impairs prostate cancer pathogenesis[J]. Chem Biol, 2011, 18(4): 476-484. DOI: 10.1016/j.chembiol.2011.02.008.
[6]	SHI WJ, LI XC, WEN HX, et al. Bioinformatics analysis of AL360181.1 regulating the progression and prognosis of colorectal cancer[J]. J Xi'an Univ (Med Sci), 2020, 41(5): 731-737. DOI: 10.7652/jdyxb202005018. 史维俊, 李欣灿, 温贺新, 等. 基因AL360181.1调节结直肠癌进展及预后的生物信息学分析[J]. 西安交通大学学报(医学版), 2020, 41(5): 731-737. DOI: 10.7652/jdyxb202005018.
[7]	YE Z, WANG S, CHEN W, et al. Fat mass and obesity-associated protein promotes the tumorigenesis and development of liver cancer[J]. Oncol Lett, 2020, 20(2): 1409-1417. DOI: 10.3892/ol.2020.11673.
[8]	LI P, LIU Y. Effect of hepatitis B x gene on the expression of major histocompatibility complex class Ⅰ chain-related gene A-A5.1, invasion, and migration of HepG2.2.15 cells[J]. J Clin Hepatol, 2020, 36(4): 808-812. DOI: 10.3969/j.issn.1001-5256.2020.04.020. 李沛, 刘宇. HBx基因对HepG2.2.15细胞MICA-A5.1表达及侵袭、迁移的影响[J]. 临床肝胆病杂志, 2020, 36(4): 808-812. DOI: 10.3969/j.issn.1001-5256.2020.04.020.
[9]	HO SY, HSU CY, LIU PH, et al. Albumin-bilirubin (ALBI) grade-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma[J]. Eur J Surg Oncol, 2019, 45(5): 776-781. DOI: 10.1016/j.ejso.2018.10.541.
[10]	YUAN SX, ZHOU WP. Progress and hot spots of comprehensive treatment for primary liver cancer[J]. Chin J Dig Surg, 2021, 20(2): 163-170. DOI: 10.3760/cma.j.cn115610-20201211-00776. 袁声贤, 周伟平. 原发性肝癌综合治疗的进展和热点[J]. 中华消化外科杂志, 2021, 20(2): 163-170. DOI: 10.3760/cma.j.cn115610-20201211-00776.
[11]	JIANG Y, SUN A, ZHAO Y, et al. Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma[J]. Nature, 2019, 567(7747): 257-261. DOI: 10.1038/s41586-019-0987-8.
[12]	LIN L, DING Y, WANG Y, et al. Functional lipidomics: Palmitic acid impairs hepatocellular carcinoma development by modulating membrane fluidity and glucose metabolism[J]. Hepatology, 2017, 66(2): 432-448. DOI: 10.1002/hep.29033.
[13]	POPE ED 3rd, KIMBROUGH EO, VEMIREDDY LP, et al. Aberrant lipid metabolism as a therapeutic target in liver cancer[J]. Expert Opin Ther Targets, 2019, 23(6): 473-483. DOI: 10.1080/14728222.2019.1615883.
[14]	NAKAGAWA H, HAYATA Y, KAWAMURA S, et al. Lipid metabolic reprogramming in hepatocellular carcinoma[J]. Cancers (Basel), 2018, 10(11): 447. DOI: 10.3390/cancers10110447.
[15]	CHISTIAKOV DA, BOBRYSHEV YV, OREKHOV AN. Macrophage-mediated cholesterol handling in atherosclerosis[J]. J Cell Mol Med, 2016, 20(1): 17-28. DOI: 10.1111/jcmm.12689.
[16]	LUCAS EK, DOUGHERTY SE, MCMEEKIN LJ, et al. PGC-1α provides a transcriptional framework for synchronous neurotransmitter release from parvalbumin-positive interneurons[J]. J Neurosci, 2014, 34(43): 14375-14387. DOI: 10.1523/JNEUROSCI.1222-14.2014.
[17]	CHIANG KP, NIESSEN S, SAGHATELIAN A, et al. An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling[J]. Chem Biol, 2006, 13(10): 1041-1050. DOI: 10.1016/j.chembiol.2006.08.008.
[18]	NOMURA DK, FUJIOKA K, ISSA RS, et al. Dual roles of brain serine hydrolase KIAA1363 in ether lipid metabolism and organophosphate detoxification[J]. Toxicol Appl Pharmacol, 2008, 228(1): 42-48. DOI: 10.1016/j.taap.2007.11.021.
[19]	CHEUNG L, FISHER RM, KUZMINA N, et al. Psoriasis skin inflammation-induced microRNA-26b targets NCEH1 in underlying subcutaneous adipose tissue[J]. J Invest Dermatol, 2016, 136(3): 640-648. DOI: 10.1016/j.jid.2015.12.008.
[20]	ZHOU A, PAN H, SUN D, et al. miR-26b-5p inhibits the proliferation, migration and invasion of human papillary thyroid cancer in a β-catenin-dependent manner[J]. Onco Targets Ther, 2020, 13: 1593-1603. DOI: 10.2147/OTT.S236319.
[21]	WANG Y, SUN B, ZHAO X, et al. Twist1-related miR-26b-5p suppresses epithelial-mesenchymal transition, migration and invasion by targeting SMAD1 in hepatocellular carcinoma[J]. Oncotarget, 2016, 7(17): 24383-24401. DOI: 10.18632/oncotarget.8328.
[22]	KHOSLA R, HEMATI H, RASTOGI A, et al. miR-26b-5p helps in EpCAM+cancer stem cells maintenance via HSC71/HSPA8 and augments malignant features in HCC[J]. Liver Int, 2019, 39(9): 1692-1703. DOI: 10.1111/liv.14188.
[23]	GUPTA M, CHANDAN K, SARWAT M. Role of microRNA and long non-coding RNA in hepatocellular carcinoma[J]. Curr Pharm Des, 2020, 26(4): 415-428. DOI: 10.2174/1381612826666200115093835.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(7)

Get Citation

PDF

XML

Article Metrics

Article views (783) PDF downloads(68)

Expression and biological role of the neutral cholesterol ester hydrolase 1 gene in liver cancer tissue and cell lines

DOI: 10.3969/j.issn.1001-5256.2021.08.023

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Expression and biological role of the neutral cholesterol ester hydrolase 1 gene in liver cancer tissue and cell lines

DOI: 10.3969/j.issn.1001-5256.2021.08.023

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content